Michael D. Nelson

Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Stroke volume decreases and end-systolic volume increases during muscle metaboreflex activation in patients with heart failure with reduced ejection fraction (HFrEF), suggesting impaired contractile reserve during muscle metaboreflex activation in patients with HFrEF. Total peripheral resistance increases similarly during muscle metaboreflex activation in patients with HFrEF compared to controls, indicating normal levels of peripheral vasoconstriction during muscle metaboreflex activation in patients with HFrEF.

Year:

2023

Mounting evidence suggests that myocardial steatosis contributes to left ventricular diastolic dysfunction, but definitive evidence in humans is lacking due to confounding comorbidities. As such, we utilized a 48‐h food restriction model to acutely increase myocardial triglyceride (mTG) content – measured by 1 H magnetic resonance spectroscopy – in 27 young healthy volunteers (13 men/14 women). Forty‐eight hours of fasting caused a more than 3‐fold increase in mTG content ( P < 0.001). Diastolic function – defined as early diastolic circumferential strain rate (CSRd) – was unchanged following the 48‐h fasting intervention, but systolic circumferential strain rate was elevated ( P < 0.001), indicative of systolic–diastolic uncoupling. Indeed, in a separate control experiment in 10 individuals, administration of low‐dose dobutamine (2 μg/kg/min) caused a similar change in systolic circumferential strain rate as was found during 48 h of food restriction, along with a proportionate increase in CSRd, such that the two metrics remained coupled. Taken together, these data indicate that myocardial steatosis contributes to diastolic dysfunction by impairing diastolic–systolic coupling in healthy adults, and suggest that steatosis may contribute to the progression of heart disease. image Key points Preclinical evidence strongly suggests that myocardial lipid accumulation (termed steatosis ) is an important mechanism driving heart disease. Definitive evidence in humans is limited due to the confounding influence of multiple underlying comorbidities. Using a 48‐h food restriction model to acutely increase myocardial triglyceride content in young healthy volunteers, we demonstrate an association between myocardial steatosis and left ventricular diastolic dysfunction. These data advance the hypothesis that myocardial steatosis may contribute to diastolic dysfunction and suggest myocardial steatosis as a putative therapeutic target.

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (11)

Ryosuke Takeda

Chukyo University

JAPAN
View details

Carol North

Professor

University of Texas Southwestern Medical Center

UNITED STATES
View details

Jakub Kolarik

VSB - Technical University of Ostrava

CZECH REPUBLIC
View details

Martina Ládrová

VSB - Technical University of Ostrava

CZECH REPUBLIC
View details

R. Matthew Brothers

-

UNITED STATES
View details

Naomi Hamburg

Associate Professor of Medicine

Boston University

UNITED STATES
View details

Mark Haykowsky

Professor, Endowed Research Chair in Aging & Quality of Life

University of Alberta

CANADA
View details

Corey R. Tomczak

-

CANADA
View details

Andrew W. D'Souza

-

CANADA
View details

Ziyad Ben Taleb

-

UNITED STATES
View details

Kerrie L. Moreau

University of Colorado Anschutz Medical Campus

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.